Cargando…
Does sacubitril/valsartan work in acute myocardial infarction? The PARADISE-AMI study
Patients with acute myocardial infarction (AMI) complicated by left ventricular dysfunction have an increased risk of death and heart failure. Numerous clinical studies have demonstrated the ability of ACE inhibitors in optimizing the outcome in this particular clinical setting. In recent years, the...
Autor principal: | Gatto, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503508/ https://www.ncbi.nlm.nih.gov/pubmed/34650362 http://dx.doi.org/10.1093/eurheartj/suab098 |
Ejemplares similares
-
Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
por: Yang, Pei, et al.
Publicado: (2022) -
Protective effect of sacubitril/valsartan in patients with acute myocardial infarction: A meta-analysis
por: Liu, Shanshan, et al.
Publicado: (2022) -
Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction
por: Ishii, Masanobu, et al.
Publicado: (2017) -
Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients
por: Wang, Bin, et al.
Publicado: (2022) -
The benefits of sacubitril–valsartan in patients with acute myocardial infarction: a systematic review and meta‐analysis
por: Xiong, Bo, et al.
Publicado: (2021)